CCM
ANGO icon

Coldstream Capital Management’s AngioDynamics ANGO Stock Holding History

Coldstream Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,161
Closed -$76.6K – 1228
2025
Q1 		$76.6K Buy
+8,161
New +$85.8K ﹤0.01% 1488

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Coldstream Capital Management's ANGO Position: Q2 2025 in Review

Coldstream Capital Management sold out of AngioDynamics (ANGO) in Q2 2025, closing a stake of 8,161 shares — an estimated $76.6K sold.

Coldstream Capital Management first reported a position in ANGO in Q1 2025 and held it in 1 quarter. The position peaked at $76.6K in Q1 2025. 150 funds tracked by Wall St. Rank hold ANGO as of Q2 2025.

  • Coldstream Capital Management reported no remaining AngioDynamics position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 8,161 AngioDynamics shares in Q2 2025, an estimated $76.6K.
  • Coldstream Capital Management first reported a position in AngioDynamics in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's AngioDynamics position peaked at $76.6K in Q1 2025.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.